Patients with pancreatic cancer who have “ultra-low baseline values” of a biomarker used for prognosis have similar survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results